entertainment -WSS

entertainment

author：knowledge 2025-09-30 12:10:24 - browse：81738

Medicare generally pays far more for CAR-T drugs that are administered in outpatient departments than it does for inpatient care. Adobe

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. But that could soon change: if drug companies succeed in making the cancer treatments safer, hospitals could provide them more often in outpatient departments, where payment is higher.

CAR-T uses the body’s own immune system to kill cancerous cells. The procedure, regulated as a drug, involves taking T cells from a patient’s blood, adding chimeric antigen receptors (CAR) to the T cells that kill cancer, and injecting the CAR-T treatment back into the patient.

It’s worked wonders in many cancer patients who have run out of options. But right now it’s almost exclusively administered in hospitals, because the side effects can require aggressive treatments. In many cases, the CAR-T cells trigger immune reactions that can be life-threatening.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Readout LOUD Podcast: Legal insider trading, booming biotech stocks

entertainment

WSS

Reanimated hearts work just as well for transplants, study finds

Clinical trials giant ICON acquires HumanFirst

RSV vaccines may be linked to small increased risk of developing GBS

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Biden administration plans revamp of organ transplant system

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

hotspot

entertainment

explore

At least 13 dead in Texas as scorching temps continue

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Medical leaders decry Supreme Court decision on affirmative action

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

The high cost of giving birth even with insurance

Obesity now affects over 1 billion people worldwide, study finds

As demand for Covid shots wanes, Moderna seeks its next success

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

23andMe had bad news about my health. I wish a person had delivered it

A public health expert passes on football's full body collisions for youths

hotspot

Biotech companies concerned about China biosecurity crackdown

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Eli Lilly’s Mounjaro succeeds in second weight

Inside the rise of 'mukbang' eating videos

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

A Q&A with Aletha Maybank, AMA’s chief health equity officer

entertainment

focus

entertainment

Wikipedia